Saturday 17 October 2026
Export BTCY’s income statement to Excel — free account
Biotricity Inc.
BTCY Healthcare Medical Devices
Biotricity Inc.’s revenue for fiscal 2026 (year ended March 2026) was $16.0 million, up 16.0% from fiscal 2025. In the quarter to June 2026, revenue grew 10.4%, EPS fell 66.7%, free cash flow grew 235.8% and total debt rose 3.48%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
0.05
0.00
0.00%
Follow BTCY
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
15.07% | 14.19% | 9.38% | 9.75% | |
Piotroski F-Score |
5 | 4 | 5 | 6 | |
| (83.81%) | (80.47%) | (51.76%) | (57.12%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
26.93% | 24.97% | 10.00% | 10.85% | |
Average Days of Receivables |
50.80 | 37.29 | 66.91 | 53.36 | |
Free Cash Flow per Share |
(0.02) | (0.04) | (0.03) | 0.01 | |
Free Cash Flow |
(0.45) | (1.10) | (0.72) | 0.16 | |
| Other line items | |||||
Cash ROIC |
6.02% | 14.78% | 9.15% | (1.96%) | |
Accounts Receivable Turnover |
8.38 | 10.98 | 6.97 | 7.70 | |
Accounts Payable Turnover |
0.36 | 0.35 | 0.37 | 0.35 | |
Inventory Turnover |
1.49 | 1.65 | 2.11 | 1.89 | |
Average Days of Payables |
949.19 | 1,065.81 | 1,073.78 | 1,117.44 | |
Days of Inventory on Hand |
270.82 | 246.66 | 160.55 | 171.19 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16.06% | 16.15% | 17.28% | 16.72% | |
Selling, General and Administrative Expense of Revenue |
66.88% | 64.02% | 53.09% | 55.20% | |
Share Based Compensation of Revenue |
10.59% | 10.09% | 0.18% | 2.22% | |
Interest Coverage |
(0.14) | 0.04 | 0.50 | 0.47 | |
Operating CF/Net income |
0.09 | 0.23 | 0.23 | (0.05) | |
Depreciation/Fixed assets |
123.77 | 147.59 | 208.83 | 368.32 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.56 | 0.56 | 0.59 | 0.71 | |
Operating CF per Share |
(0.02) | (0.04) | (0.03) | 0.01 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 28 Sep 2026